PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33809319-1	2021	Phosphodiesterase type 5 (PDE5) inhibitors such as Viagra  (sildenafil citrate) have demonstrated efficacy in the treatment of erectile dysfunction (ED) by inducing cyclic guanosine monophosphate (cGMP) elevation followed by vasodilation and increased blood flow.	Sildenafil Citrate	51-57	phosphodiesterase 5A	Homo sapiens	0-24	
33809319-1	2021	Phosphodiesterase type 5 (PDE5) inhibitors such as Viagra  (sildenafil citrate) have demonstrated efficacy in the treatment of erectile dysfunction (ED) by inducing cyclic guanosine monophosphate (cGMP) elevation followed by vasodilation and increased blood flow.	Sildenafil Citrate	51-57	phosphodiesterase 5A	Homo sapiens	26-30	
33809319-1	2021	Phosphodiesterase type 5 (PDE5) inhibitors such as Viagra  (sildenafil citrate) have demonstrated efficacy in the treatment of erectile dysfunction (ED) by inducing cyclic guanosine monophosphate (cGMP) elevation followed by vasodilation and increased blood flow.	Sildenafil Citrate	60-78	phosphodiesterase 5A	Homo sapiens	0-24	
33809319-1	2021	Phosphodiesterase type 5 (PDE5) inhibitors such as Viagra  (sildenafil citrate) have demonstrated efficacy in the treatment of erectile dysfunction (ED) by inducing cyclic guanosine monophosphate (cGMP) elevation followed by vasodilation and increased blood flow.	Sildenafil Citrate	60-78	phosphodiesterase 5A	Homo sapiens	26-30